John Francis William Deakin

Affiliations: 
 
Google:
"John Deakin"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koychev I, El-Deredy W, Mukherjee T, et al. (2012) Core dysfunction in schizophrenia: electrophysiology trait biomarkers. Acta Psychiatrica Scandinavica. 126: 59-71
Rylands AJ, McKie S, Elliott R, et al. (2011) A functional magnetic resonance imaging paradigm of expressed emotion in schizophrenia. The Journal of Nervous and Mental Disease. 199: 25-9
Oliveira RM, Guimarães FS, Deakin JF. (2008) Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De Biofã­Sica ... [Et Al.]. 41: 333-41
Hallak JE, Crippa JA, Pinto JP, et al. (2007) Total agenesis of the corpus callosum in a patient with childhood-onset schizophrenia. Arquivos De Neuro-Psiquiatria. 65: 1216-9
Toro CT, Hallak JE, Dunham JS, et al. (2006) Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neuroscience Letters. 404: 276-81
Dursun SM, Hallak JE, Haddad P, et al. (2005) Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index? Journal of Psychopharmacology (Oxford, England). 19: 432-3
Guarnieri R, Wichert-Ana L, Hallak JE, et al. (2005) Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study. Psychiatry Research. 138: 75-84
Hallak JE, Dursun SM, Guarnieri R, et al. (2003) Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy. Journal of Psychopharmacology (Oxford, England). 17: 350-1
Dursun SM, Deakin JF. (2001) Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study. Journal of Psychopharmacology (Oxford, England). 15: 297-301
See more...